Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02045459 · ClinicalTrials.gov registry record · NA
Microvascular Disease Exercise Trial
A NA study of Coronary Microvascular Disease, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
- 2
- Study locations
NCT02045459 is a NA study of Coronary Microvascular Disease that has completed, run by University of Virginia. The registered enrollment target is 79 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT02045459, a NA study of Coronary Microvascular Disease, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
- 2
- Study locations
Study Summary
For part of this study, we are collecting information from patients that have been experiencing the symptoms mentioned above. We are taking this information and creating a chest pain registry to follow trends and compare different patients having similar symptoms. We hope to gain insight into the quality of life, symptoms, and cardiac events of those who are having similar symptoms. The type of information we will collect includes: demographics, quality of life, levels of anxiety related to angina pain and cardiac events occurring within a 2 year period of time. In addition, we are performing a cardiac stress MRI for research purposes to look at the blood flow in the small vessels in your heart. During the stress cardiac MRI, we will give you a medication called Regadenoson (Lexiscan) which "stresses" your heart by dilating the blood vessels to your heart. This drug is approved by the U.S. Food and Drug Administration (FDA) for this purpose. We will then be able to measure the myocardial perfusion reserve (MPR) which is a measure of blood flow through the small blood vessels to see if an abnormal MPR and small blood vessel disease is associated with an increased risk of cardiovascular events, such as heart attack. At this point, there is no specific therapy for small vessel disease. In addition we have phase II of this study which is to determine if exercise and intensive medical therapy together compared to intensive medical therapy alone improves pain from the heart and improves overall quality of life.
Conditions Studied
Interventions
- BEHAVIORAL Exercise Program
Study Locations (2)
Virginia
- University of Virginia - Charlottesville
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2014-05 |
| Est. Completion | 2021-05-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02045459
The ClinicalTrials.gov registry entry for NCT02045459 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Microvascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Exercise Program is the first listed.
NCT02045459 reports 2 study locations spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT02045459 about?
NCT02045459 is a clinical study titled "Microvascular Disease Exercise Trial". For part of this study, we are collecting information from patients that have been experiencing the symptoms mentioned above. We are taking this information and creating a chest pain registry to follow trends and compare different patients having similar symptoms. We hope to gain insight into the qu...
What is the current status of trial NCT02045459?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2014-05. Estimated completion is 2021-05-17.
What conditions does trial NCT02045459 study?
This clinical trial studies the following conditions: Coronary Microvascular Disease.
What interventions are being tested in trial NCT02045459?
The interventions under investigation include: Exercise Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02045459?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02045459 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Microvascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.